Ragusa F - Search Results

1

Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?

Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Paparo SR, Patrizio A, Mazzi V, Colaci M, Giuggioli D, Ferri C, Antonelli A. Ferrari SM, et al. Among authors: ragusa f. J Immunol Res. 2019 Aug 8;2019:5878960. doi: 10.1155/2019/5878960. eCollection 2019. J Immunol Res. 2019. PMID: 31485460 Free PMC article. Review.

2

Th1 chemokines in ulcerative colitis.

Ragusa F. Ragusa F. Clin Ter. 2015;166(2):e126-31. doi: 10.7417/CT.2015.1835. Clin Ter. 2015. PMID: 25945446

3

Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.

Fallahi P, Ferrari SM, Ruffilli I, Ragusa F, Biricotti M, Materazzi G, Miccoli P, Antonelli A. Fallahi P, et al. Among authors: ragusa f. Expert Opin Drug Deliv. 2017 May;14(5):647-655. doi: 10.1080/17425247.2016.1227782. Epub 2016 Aug 30. Expert Opin Drug Deliv. 2017. PMID: 27552635 Review.

4

Mesothelioma and interferon-γ-dependent chemokine IP-10.

Fallahi P, Ragusa F. Fallahi P, et al. Among authors: ragusa f. Clin Ter. 2016 Nov-Dec;167(6):e192-e197. Clin Ter. 2016. PMID: 28051835

5

IP-10 in occupational asthma: review of the literature and case-control study.

Ragusa F, Fallahi P. Ragusa F, et al. Clin Ter. 2017 Mar-Apr;168(2):e151-e157. doi: 10.7417/CT.2017.1998. Clin Ter. 2017. PMID: 28383629 Free article. Review.

6

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity.

Ruffilli I, Ragusa F, Benvenga S, Vita R, Antonelli A, Fallahi P, Ferrari SM. Ruffilli I, et al. Among authors: ragusa f. Front Endocrinol (Lausanne). 2017 Jun 19;8:139. doi: 10.3389/fendo.2017.00139. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28674524 Free PMC article. Review.

7

Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis.

Ferrari SM, Fallahi P, Santaguida G, Virili C, Ruffilli I, Ragusa F, Centanni M, Antonelli A. Ferrari SM, et al. Among authors: ragusa f. Autoimmun Rev. 2017 Sep;16(9):946-950. doi: 10.1016/j.autrev.2017.07.006. Epub 2017 Jul 8. Autoimmun Rev. 2017. PMID: 28698095

8

Sunitinib in the Treatment of Thyroid Cancer.

Ferrari SM, Centanni M, Virili C, Miccoli M, Ferrari P, Ruffilli I, Ragusa F, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: ragusa f. Curr Med Chem. 2019;26(6):963-972. doi: 10.2174/0929867324666171006165942. Curr Med Chem. 2019. PMID: 28990511 Review.

9

Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.

Ferrari SM, Bocci G, Di Desidero T, Elia G, Ruffilli I, Ragusa F, Orlandi P, Paparo SR, Patrizio A, Piaggi S, La Motta C, Ulisse S, Baldini E, Materazzi G, Miccoli P, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: ragusa f. Oncol Rep. 2018 May;39(5):2225-2234. doi: 10.3892/or.2018.6306. Epub 2018 Mar 8. Oncol Rep. 2018. PMID: 29517103

10

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo.

Ferrari SM, Bocci G, Di Desidero T, Ruffilli I, Elia G, Ragusa F, Fioravanti A, Orlandi P, Paparo SR, Patrizio A, Piaggi S, La Motta C, Ulisse S, Baldini E, Materazzi G, Miccoli P, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: ragusa f. Oncol Rep. 2018 May;39(5):2306-2314. doi: 10.3892/or.2018.6305. Epub 2018 Mar 8. Oncol Rep. 2018. PMID: 29517106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page